×
0.0688622754491019 0.0688622754491019 0.0688622754491019 0.0688622754491019 0.0688622754491019 0.0688622754491019 0.000598802395209675 -0.0131736526946107
Stockreport

Athenex Receives Promising Innovative Medicine Designation from the United Kingdom MHRA for Oraxol, An Innovative Oral Form of Paclitaxel

ATHENEX (ATNX)  More Company Research Source: GlobeNewswire
US:NASDAQ Investor Relations: ir.athenex.com
PDF BUFFALO, N.Y., Dec. 27, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) granted a Promising Innovative Medicine (PIM) designation for Oraxol in the treatment of paclitaxel-responsive cancers.  Oraxol is an innovative development in the treatment of cancer, in that it is an oral formulation of paclitaxel, a very effective and commonly used chemotherapy treatment for many cancers. The existing marketed form of paclitaxel can only be administered intravenously. It cannot be absorbed orally because it is is excreted by gastrointestinal cells via the P-glycoprotein (P-gp) pump before it can be absorbed. Athenex had enabled oral administration of paclitaxel by combining HM30181A with oral paclitaxel (called Oraxol), which was initi [Read more]

IMPACT SNAPSHOT EVENT TIME: ATNX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS